Details
ScreenPoint Medical is a medical technology company focused on applying artificial intelligence to breast cancer detection and screening. Headquartered in Nijmegen, Netherlands, the company develops AI-powered software that supports radiologists in interpreting mammography and breast imaging with higher accuracy and efficiency.
Its flagship product, Transpara, uses deep learning algorithms to analyze 2D and 3D mammograms, helping detect potential cancers earlier, improve diagnostic confidence, and support workflow efficiency in screening programs. The technology is designed to assist radiologists by highlighting areas of interest and supporting decision making in clinical practice.
ScreenPoint Medical operates with a strong research driven foundation, combining expertise in medical imaging, machine learning, and clinical science. The company works closely with hospitals, research institutions, and healthcare partners worldwide to validate and improve its solutions in real-world screening environments.
Employees work in a highly specialized and mission driven environment across AI development, clinical research, software engineering, and medical affairs, contributing to technologies aimed at improving early cancer detection and patient outcomes.